News & Updates

The KATMAP model, developed by researchers in the Department of Biology, can predict alternative cell splicing, which allows cells to create endless diversity from the same sets of genetic blueprints.

MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.

Targeted particles carrying the cytokine IL-12 can jump-start T cells, allowing them to clear tumors while avoiding side effects.

The technology would allow battery-free, minimally invasive, scalable bioelectronic implants such as pacemakers, neuromodulators, and body process monitors.

Selective crystallization can greatly improve the purity, selectivity, and active yield of viral vector-based gene therapy drugs, MIT study finds.

Adding amino acids to certain protein-based medications can improve stability and effectiveness. New MIT research demonstrates how it works.

The scanning electron microscopy image associated with this journal publication and featured on the cover of the Journal of Physical Chemistry was taken at Characterization.nano!

Read the publication

An alternative to massive particle colliders, the approach could reveal insights into the universe’s starting ingredients.

An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.